IGF2BP3 and neoplasm: Previous studies revealed that IGF2BP3 promoted tumor proliferation and progression in colorectal cancer, gastric cancer, and glioblastoma (Suvasini et al., 2011; Zhou et al., 2017; Xu et al., 2019).